InVivoMAb anti-human CD32 (FcgammaRIIA)

Walsh TG, Harper MT, Poole AW. SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4. Cell Signal. 2015,27(1):37-46. doi: 10.1016/j.cellsig.2014.09.021

Flinsenberg TWH, Janssen WJ, Herczenik E, et al. A novel FcγRIIa Q27W gene variant is associated with common variable immune deficiency through defective FcγRIIa downstream signaling. Clin Immunol. 2014,155(1):108-117. doi: 10.1016/j.clim.2014.09.006

Ben Mkaddem S, Hayem G, Jönsson F, et al. Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. J Clin Invest. 2014,124(9):3945-59. doi: 10.1172/JCI74572

Trist HM, Tan PS, Wines BD, et al. Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses. J Immunol. 2014,192(2):792-803. doi: 10.4049/jimmunol.1301554

Stemerding AM, Köhl J, Pandey MK, et al. Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions. J Immunol. 2013,191(1):353-62. doi: 10.4049/jimmunol.1203243

van der Aar AM, Picavet DI, Muller FJ, et al. Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells. J Invest Dermatol. 2013,133(5):1240-9. doi: 10.1038/jid.2012.500

Veri MC, Gorlatov S, Li H, et al. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization. Immunology. 2007,121(3):392-404.

Brown MG, King CA, Sherren C, et al. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol. 2006,80(6):1242-50.